PMB growing in Japan and Israel
Mergermarket, an Acuris company, has released full year 2017 Pharma, Medical & Biotech (PMB) report
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Dr Reddy’s Q2 Revenues at Rs 35.5 Bn
H1 Revenues at Rs 68.6 Bn, Q2 EBITDA at Rs 6.9 Bn
Sanofi, Regeneron accelerate investment for clinical development
The companies collaborate for the clinical development of PD-1 antibody cemiplimab in oncology and dupilumab in Type 2 allergic…
FDD Leaders Handbook
FDD Leaders Handbook featured the leaders in formulation development and drug delivery who are helming India’s journey to become…
Lynparza approved by US FDA
Lynparza is the first and only PARP inhibitor approved for use beyond ovarian cancer
Lupin forays into OTC segment
Launches Softovac under the umbrella of Lupin Life Consumer Healthcare
Glenmark initiates Phase IIb dose range finding study
The study will evaluate safety and efficacy of GRC 27864 in patients with moderate osteoarthritic pain
Intas acquires generics business of Actavis in UK, Ireland
This acquisition is set to more than double Intas' pan-European operations, with pro-forma revenues exceeding $500 million
Livongo and Lilly collaborate on real-world diabetes research
Companies join forces to advance predictive and prescriptive recommendations for people with diabetes
Eisai set-ups new OSD production facility in China
Operations are expected to commence in the second half of fiscal 2018